Frequency of Retinopathy Among Newly Diagnosed Patients with Diabetes Mellitus

Abstract

Background and Aims: Diabetes mellitus (DM) is a significant public health issue in Saudi Arabia. Diabetic retinopathy (DR) is one of the serious complications related to DM and considered an important cause of blindness. Understanding of the demographic and clinical characteristics associated with DR is important to inform effective management strategies. Therefore, the aim of the current study is to determine the prevalence and associated risk factors of DR among newly diagnosed type 2 diabetic patients in Al-Qassim University Hospital. Methods: This retrospective cross-sectional study was conducted at Qassim University Hospital, Saudi Arabia, from July to September 2024. The study included all newly diagnosed type 2 diabetic patients with complete medical records in the diabetes clinics. Demographic data and clinical parameters were collected. Results: The study included 77 patients, with a mean age of 51 years (SD ≤ 13.03) and a mean diabetes duration of 15.6 months (SD ≤ 8.22). Diabetic retinopathy was present in 7.8% of patients, while neuropathy and nephropathy had very low prevalence rates of 3.9% and 2.6%, respectively. No statistically significant associations were observed between demographic or clinical factors and the prevalence of retinopathy (p > 0.05). Conclusion: This study revealed low rates of diabetic complications among the sample, possibly due to the short duration of diabetes in most patients. The lack of significant associations between complications and factors like HbA1c or blood pressure underscores the complexity of diabetic complications and suggests that long-term studies are needed to capture these relationships fully.

References

1. 1.Danaei G,Finucane MM,Lu Y,Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011;378:31-40.
2. 2.Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J. 2004;25:1603-1610.
3. 3.Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in 82 Majmaah Journal of Health Sciences,Vol.13, Issue4, October-2025,Rabi-Althani-1447 Frequency of RetinopathyAmongNewlyDiagnosedPatientswithDiabetesMellitus a Saudi community. Ann Saudi Med. 2011;31:19-23.
4. 4.Cade WT. Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting. Phys Ther. 2008;88:1322-1335.
5. 5.Fong DS,Aiello L,Gardner TW,King GL, Blankenship G, Cavallerano JD, et al. Diabetic Retinopathy. Diabetes Care. 2003;26:99-102.
6. 6.AlGhamdiAH,RabiuM,HajarS,Yorston D, Kuper H, Polack S. Rapid assessment of avoidable blindness and diabeticretinopathyinTaif,SaudiArabia. Br J Ophthalmol. 2012;96:1168-1172.
7. 7.El-Bab MF, Shawky N, Al-Sisi A, Akhtar M. Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia. Clin Ophthalmol. 2012:269.
8. 8.Khan A,Wiseberg J, Lateef ZA, Khan S. Prevalence and determinants of diabetic retinopathy in Al Hasa region of Saudi Arabia: primary health care centre based cross-sectional survey, 2007- 2009. Middle East Afr J Ophthalmol. 2010;17:257.